COMMUNIQUÉS West-GlobeNewswire

Inaugural Eye Health Summit Empowers Public with Integrative Vision Care Insights from Leading Experts
19/02/2025
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The Eye Health Summit , a new global patient-centered event dedicated to integrative eye health, will take place May 1–7 as a free hybrid event. Hosted and produced by [...]
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025
On-demand video webcast now available here LA JOLLA, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural [...]
Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies
19/02/2025
New Patent covers claims which focus on method for identifying genetic markers in patients with alcohol or opioid related disorders Patent expands the identification of potential treatment candidates for AD04 [...]
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
19/02/2025
The company received a certificate of Good Manufacturing Practice (GMP) compliance following an inspection of their Montreal facility by the European Medicines Agency MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) -- C3i [...]
Le Centre C3i, une compagnie canadienne, reçoit l'approbation de l’EMA pour fabriquer des produits de thérapie cellulaire pour le marché européen
19/02/2025
La société a reçu une certification de conformité aux Bonnes pratiques de fabrications (BPF) à la suite d’une inspection de leur installation à Montréal par l'Agence européenne des médicaments MONTRÉAL, 19 févr. 2025 ( [...]
Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
19/02/2025
On-demand video webcast now available here BOSTON and LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody [...]
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025, at 8:00 a.m. ET
18/02/2025
PRINCETON, N.J., Feb. 18, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its fourth quarter and full year 2024 financial results [...]
Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call and Webcast on Tuesday, February 25, 2025, at 8:00 a.m. ET
18/02/2025
CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
18/02/2025
MOUNTAIN VIEW, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE) today announced the completion of its previously announced underwritten public offering of 7,475,000 shares of its common stock at [...]
Lyell Immunopharma Announces Participation in Upcoming Investor Conferences
18/02/2025
SOUTH SAN FRANCISCO, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, [...]
InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
18/02/2025
JENA, Germany, Feb. 18, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that [...]
Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025
18/02/2025
SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]
HealthEquity Reports Year-End Sales Metrics
18/02/2025
Affirms Business Outlook, Announces Upcoming Events and Presentations DRAPER, Utah, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health [...]
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18/02/2025
DURHAM, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on February 12, 2025, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to three new [...]
Trio of Seasoned Healthcare Leaders Joins Greenhouse Treatment Center’s Executive Team
18/02/2025
GRAND PRAIRIE, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Greenhouse Treatment Center has announced the appointment of three experienced healthcare professionals to its executive team. The Texas-based addiction treatment [...]
Highsman Releases HIT STICKS in MA, Creating an Entirely New Single-Use Cannabis Product Category
18/02/2025
Legendary NFL running back Ricky Williams’ newest cannabis product delivers potency, convenience and affordability in every innovative puff BOSTON, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Legendary NFL running back Ricky [...]
Common Myths About Non-Surgical Hair Replacement Systems Debunked by Folicure Dallas Hair Experts
18/02/2025
Discover the truth about non-surgical hair replacement: lightweight, natural, cost-effective, and low-maintenance solutions designed for confidence. Explore custom options with Folicure. Dallas, TX, Feb. 18, 2025 (GLOBE [...]
Notice of Capital Markets Day - Save the Date
18/02/2025
Louvain-la-Neuve, Belgium, 18 February, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, will host a Capital Markets Day (CMD) for investors and analysts on Monday [...]
Capital Markets Day - Save the Date
18/02/2025
Louvain-la-Neuve, Belgique, le 18 février 2025 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial de la technologie des accélérateurs de particules, organise un Capital Markets Day (CMD), session d’information [...]

Pages